Federal grant · project grant (b)
Machine Vision Guided Robotics for Automated Microinjections Into Fruit Fly Embryos - Project Summary Objective Biotechnology Is a Spin-out From the University of Minnesota That Is Pioneering the Use of Machine Vision Guided Robots for Automating Precise Microbiology Procedures Such as Microinjection. Drosophila Melanogaster (fruit Fly) Is a Model Organism Extensively Used in Both Basic and Clinical Research. a Key Challenge in Drosophila Biological Research Is the Bottleneck of Generating and Maintaining Transgenic Lines of Flies. Traditionally, Transgenesis Involves Skilled Technicians Performing Intricate and Precise Microinjection Procedures Repeatedly. However, Objective Biotechnology Inc. Has Introduced an Innovative Solution - a Machine Vision Guided Robot Designed to Automate the Microinjection Process for Drosophila Melanogaster Embryos. This Technology Can Also Be Adapted for Use With Various Other Organisms. This Robot Eliminates the Need for Manual Microinjection Protocols, Which Are Operator-dependent, Time-consuming, and Require Significant Training. the Robot Uses Machine Learning (ML) Models Trained to Detect Individual Embryos on Agar Plates and Guides Microinjection Needles to Perform Microinjections at Specific Locations in Each Detected Embryo. This Robot Can Be Operated by Individuals With No Prior Experience and Surpass Human Capabilities in Terms of Microinjection Speed, Performing at a Rate Six Times Faster Than Humans. in Aim 1 of This Proposal, We Will Evaluate the Efficacy and Generalizability of the Autoinjector Technology for Transgenesis Across a Wide Spectrum of Drosophila Experiments. This Involves Testing and Refining the Automated Microinjection Process for Different Genetic Backgrounds, Microinjection Locations, Microinjectant Compositions, Construct Sizes, Auxiliary Plasmids or Transgenes, as Well as Various Operational Variables Such as Embryo Laying Conditions, Culture Media, Dna Concentration, and Solution Viscosity. Aim 2 of This Proposal We Will Innovate the ML Algorithms to Address Two Identified Failure Modes in the Automated Microinjection Process. These Failure Modes Are (1) the Inability to Detect Individual Embryos When They Are Clustered Together on the Embryo Collection Plates and (2) the Clogging of Pipettes During Automated Microinjection. We Will Develop Ml-guided Robotic Algorithms to Mitigate These Issues and Improve the Overall Performance of the System.
Committed
$294,543
Loading…
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then unspent ceiling.